1,799
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Thermal dosimetry for bladder hyperthermia treatment. An overview

, , , , , , , , , , , & show all
Pages 417-433 | Received 14 Dec 2015, Accepted 16 Feb 2016, Published online: 01 May 2016

References

  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.
  • Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BWG, Compérat E, et al. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: Update 2013. Eur Urol 2013;64:639–53.
  • Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: Progression and recurrence. J Urol 1983;130:1083–6.
  • Sylvester RJ, van der Meijden APM, Lamm DL. Intravesical bacillus Calmette–Guérin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials. J Urol 2002;168:1964–70.
  • Ehdaie B, Sylvester R, Herr HW. Maintenance bacillus Calmette–Guérin treatment of non–muscle-invasive bladder cancer: A critical evaluation of the evidence. Eur Urol 2013;64:579–85.
  • Lamm DL, van der Meijden APM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette–Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596–600.
  • van der Heijden AG, Jansen CFJ, Verhaegh G, O’Donnell MA, Schalken JA, Witjes JA. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 2004;46:670–4.
  • Lammers RJM, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60:81–93.
  • Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 2011;107:912–18.
  • Sousa A, Inman BA, Piñeiro I, Monserrat V, Pérez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:166–70.
  • Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5.
  • Geijsen ED, de Reijke TM, Koning CC, Vörde Sive Vörding PJ Zum, de la Rosette JJ, Rasch CR, et al. Combining mitomycin C and regional 70 MHz hyperthermia in patients with nonmuscle invasive bladder cancer: A pilot study. J Urol 2015;194:1202–8.
  • Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001;19:666–75.
  • Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176:2414–22; discussion 2422.
  • Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008;180:121–7.
  • Visser O, Nieuwenhuijzen JA, Horenblas S, Members of the Urological Oncology Working Group of the Comprehensive Cancer Centre Amsterdam. Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater Amsterdam. J Urol 2005;174:97–102.
  • Munro NP, Sundaram SK, Weston PMT, Fairley L, Harrison SCW, Forman D, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. Int J Radiat Oncol Biol Phys 2010;77:119–24.
  • Arcangeli G, Strigari L, Arcangeli S. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review of clinical trials. Crit Rev Oncol Hematol 2015;95:387–96.
  • Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: A systematic review. Eur Urol 2014;66:120–37.
  • James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012;366:1477–88.
  • van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 2000;355(9210):1119–25.
  • Ott OJ, Rödel C, Weiss C, Wittlinger M, St Krause F, Dunst J, et al. Radiochemotherapy for Bladder Cancer. Clin Oncol 2009;21:557–65.
  • Wittlinger M, Rödel CM, Weiss C, Krause SF, Kühn R, Fietkau R, et al. Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009;93:358–63.
  • Griffin RJ, Dings RPM, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: Role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010;26:256–63.
  • Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 2009;25:91–5.
  • Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005;21:761–7.
  • Oei AL, van Leeuwen CM, ten Cate R, Rodermond HM, Buist MR, Stalpers LJA, et al. Hyperthermia selectively targets human papillomavirus in cervical tumors via p53-dependent apoptosis. Cancer Res 2015;75:5120–9.
  • Oei AL, Vriend LEM, Crezee J, Franken NAP, Krawczyk PM. Effects of hyperthermia on DNA repair pathways: One treatment to inhibit them all. Radiat Oncol 2015;10:1–13.
  • Bergs JWJ, Krawczyk PM, Borovski T, ten Cate R, Rodermond HM, Stap J, et al. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair 2013;12:38–45.
  • Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA 2011;108:9851–6.
  • Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9.
  • Arends TJH, Falke J, Lammers RJM, Somford DM, Hendriks JCM, de Weijert MCA, et al. Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia. World J Urol 2015 Oct;33:1411–17.
  • Paroni R, Salonia A, Lev A, Da Pozzo LF, Cighetti G, Montorsi F, et al. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 2001;52:273–8.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984;10:787–800.
  • Dewhirst MW, Abraham J, Viglianti B. Evolution of thermal dosimetry for application of hyperthermia to treat cancer. In: Sparrow EM, Abraham JP, Gorman JM, editor. Advances in heat transfer. Waltham, MA: Academic Press; 2015 p. 397–421.
  • Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267–94.
  • Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998;14:125–33.
  • Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011;187: 605–10.
  • Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: An update. Int J Hyperthermia 2011;27:320–43.
  • Nah BS, Choi IB, Oh WY, Osborn JL, Song CW. Vascular thermal adaptation in tumors and normal tissue in rats. Int J Radiat Oncol Biol Phys 1996;35:95–101.
  • Lin JC, Song CW. Influence of vascular thermotolerance on the heat-induced changes in blood flow, pO2, and cell survival in tumors. Cancer Res 1993;53:2076–80.
  • Van Rhoon GC. Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia 2016;32:50–62.
  • Franckena M, Fatehi D, de Bruijne M, Canters RAM, van Norden Y, Mens JW, et al. Hyperthermia dose–effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009;45:1969–78.
  • Thrall DE, Maccarini P, Stauffer P, Macfall J, Hauck M, Snyder S, et al. Thermal dose fractionation affects tumour physiological response. Int J Hyperthermia 2012;28:431–40.
  • Crezee J, van Leeuwen CM, Oei AL, Stalpers LJ, Bel A, Franken NA, et al. Thermoradiotherapy planning: Integration in routine clinical practice. Int J Hyperthermia 2016;32:41–9.
  • Bruggmoser G. Some aspects of quality management in deep regional hyperthermia. Int J Hyperthermia 2012;28:562–9.
  • Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: Quality management in regional deep hyperthermia. Strahlenther Onkol 2012;188(Suppl2):198–211.
  • Yuan Y, Cheng K-S, Craciunescu OI, Stauffer PR, Maccarini PF, Arunachalam K, et al. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys 2012;39:1170–1181.
  • Bondar ML, Hoogeman MS, Mens JW, Quint S, Ahmad R, Dhawtal G, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys 2012;83:1617–23.
  • van de Schoot AJAJ, Schooneveldt G, Wognum S, Hoogeman MS, Chai X, Stalpers LJA, et al. Generic method for automatic bladder segmentation on cone beam CT using a patient-specific bladder shape model. Med Phys 2014;41:031707.
  • Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, et al. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:176–83.
  • Cordeiro ER, Geijsen DE, Vörde Sive Vörding PJ Zum, Schooneveldt G, Sijbrands J, Hulshof MC, et al. Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: Technical feasibility study. J Endourol 2013;27:1504–9.
  • Schooneveldt G, Kok HP, Geijsen ED, van Ommen F, Bakker A, Westendarf Zanartu MA, et al. Improved temperature monitoring and treatment planning for loco-regional hyperthermia treatments of non-muscle invasive bladder cancer (NMIBC). In: Jaffray DA, editor. World Congress on Medical Physics and Biomedical Engineering, June 7–12, 2015, Toronto, Canada. Cham: Springer International, 2015, pp. 1691–4.
  • Stauffer PR, Van Rhoon GC. Overview of bladder heating technology. Matching capabilities with clinical requirements. Int J Hyperthermia. 2016;32.
  • Sousa A, Piñeiro, I, Aparici V, Neira P, Monserrat V, Uribarri C. Análisis del impacto presupuestario del tratamiento mediante quimiohipertermia neoadyuvante en el cáncer vesical no músculo invasivo [Analysis of the budgetary impact of neo-adjuvant chemohyperthermia treatment of non-muscle invasive bladder cancer]. Urol Oncológica 2015;68:482–492.
  • Sousa Escandon A. Conductive hyperthermia for bladder cancer. Int J Hyperthermia 2016;32.
  • Rigatti P, Lev A, Colombo R. Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study. Eur Urol 1991;20:204–10.
  • van Valenberg H, Colombo R, Witjes JA. Intravesical radiofrequency induced hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2016;32.
  • Colombo R, Salonia A, Da Pozzo LF, Naspro R, Freschi M, Paroni R, et al. Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: Preliminary clinical experience. Crit Rev Oncol Hematol 2003;47:127–39.
  • Rath-Wolfson L, Moskovitz B, Dekel Y, Kugel V, Koren R. Combined intravesical hyperthermia and mitomycin chemotherapy: A preliminary in vivo study. Int J Exp Pathol 2003;84:145–52.
  • Abe M, Hiraoka M, Takahashi M, Egawa S, Matsuda C, Onoyama Y, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 1986;58:1589–95.
  • Longo TA, Gopalakrishna A, Tsivian M, van Noord M, Inman BA, Geijsen ED. A systematic review of regional hyperthermia therapy in bladder cancer. Int J Hyperthermia 2016;32.
  • Paulides MM, Stauffer PR, Neufeld E, Maccarini PF, Kyriakou A, Canters RAM, et al. Simulation techniques in hyperthermia treatment planning. Int J Hyperthermia 2013;29:346–57.
  • Kok HP, Ciampa S, de Kroon-Oldenhof R, Steggerda-Carvalho EJ, van Stam G, Vörde Sive Vörding PJ Zum, et al. Toward online adaptive hyperthermia treatment planning: Correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int J Radiat Oncol Biol Phys 2014;90:438–45.
  • Canters RAM, Paulides MM, Franckena MF, van der Zee J, van Rhoon GC. Implementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: an overview and the Rotterdam experience. Int J Hyperthermia 2012;28:570–81.
  • Kok H, Wust P, Stauffer P, Bardati F, van Rhoon G, Crezee J. Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol 2015;10:196.
  • Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 2007;183:479–86.
  • Gellermann J, Włodarczyk W, Hildebrandt B, Ganter H, Nicolau A, Rau B, et al. Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 2005;65:5872–80.
  • Gellermann J, Hildebrandt B, Issels R, Ganter H, Włodarczyk W, Budach V, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: Correlation with response and direct thermometry. Cancer 2006;107:1373–82.
  • Oliveira TR, Stauffer PR, Lee C-T, Landon CD, Etienne W, Ashcraft KA, et al. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study. Int J Hyperthermia 2013;29:835–44.
  • Landon C, Lee C-T, Ashcraft KA, Oliveira TR, Boss M, Stauffer PR, et al. Toxicity concerns regarding the use of coated iron oxide magnetic particles for intravesicular bladder heating. Int J Hyperthermia in press.
  • Cox RS, Kapp DS. Correlation of thermal parameters with outcome in combined radiation therapy–hyperthermia trials. Int J Hyperthermia 1992;8:719–32.
  • Hand JW, Machin D, Vernon CC, Whaley JB. Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 1997;13:343–64.
  • Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995;33:887–99.
  • Leopold KA, Dewhirst MW, Samulski TV, Dodge RK, George SL, Blivin JL, et al. Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 1993;25:841–7.
  • Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993;25:289–97.
  • Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial. Int J Radiat Oncol Biol Phys 1997;39:371–80.
  • Wust P, Stahl H, Dieckmann K, Scheller S, Löffel J, Riess H, et al. Local hyperthermia of N2/N3 cervical lymph node metastases: Correlation of technical/thermal parameters and response. Int J Radiat Oncol Biol Phys 1996;34:635–46.
  • van der Zee J, van Rhoon GC, Wike-Hooley JL, Reinhold HS. Clinically derived dose effect relationship for hyperthermia given in combination with low dose radiotherapy. Br J Radiol 1985;58(687):243–50.
  • Overgaard J, González González D, Hulshof MCCM, Arcangeli G, Dahl O, Mella O, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. a multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia 2009;25:323–34.
  • Dinges S, Harder C, Wurm R, Buchali A, Blohmer J, Gellermann J, et al. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial. Strahlenther Onkol 1998;174:517–21.
  • Sreenivasa G, Hildebrandt B, Kümmel S, Jungnickel K, Cho CH, Tilly W, et al. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or = FIGO IIB ‘bulky’. Int J Radiat Oncol Biol Phys 2006;66:1159–67.
  • Rau B, Wust P, Hohenberger P, Löffel J, Hünerbein M, Below C, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial. Ann Surg 1998;227:380–9.
  • Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000;48:381–91.
  • Craciunescu OI, Stauffer PR, Soher BJ, Wyatt CR, Arabe O, Maccarini P, et al. Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. Med Phys 2009;36:4848–58.
  • Gellermann J, Włodarczyk W, Feussner A, Fähling H, Nadobny J, Hildebrandt B, et al. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia 2005;21:497–513.
  • Saccomandi P, Schena E, Silvestri S. Techniques for temperature monitoring during laser-induced thermotherapy: An overview. Int J Hyperthermia 2013;29:609–19.
  • Colombo R. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003;21:4270–6.
  • Colombo R, Moschini M. Ruolo della chemio-ipertermia endocavitaria a microonde nel trattamento delle neoplasie vescicali non muscolo invasive. Una revisione sistematica della letteratura [Role of the combined regimen with local chemotherapy and microwave-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review]. Urologia 2013;80:112–19.
  • Gofrit O., Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004;63:466–71.
  • van der Heijden A, Kiemeney L, Gofrit O, Nativ O, Sidi A, Leib Z, et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 2004;46:65–72.
  • Schena E, Majocchi L. Assessment of temperature measurement error and its correction during Nd:YAG laser ablation in porcine pancreas. Int J Hyperthermia 2014;30:328–34.
  • de Leeuw AA, Crezee J, Lagendijk JJ. Temperature and SAR measurements in deep-body hyperthermia with thermocouple thermometry. Int J Hyperthermia 1993;9:685–97.
  • Dickinson RJ. Thermal conduction errors of manganin-constantan thermocouple arrays. Phys Med Biol 1985;30:445–53.
  • Steinhart JS, Hart SR. Calibration curves for thermistors. Deep Sea Res Oceanogr Abstr 1968;15:497–503.
  • Salahi S, Maccarini PF, Rodrigues DB, Etienne W, Landon CD, Inman BA, et al. Miniature microwave applicator for murine bladder hyperthermia studies. Int J Hyperthermia 2012;28:456–65.
  • Stauffer P, Craciunescu O, Maccarini P, Wyatt C, Arunachalam K, Arabe O, et al. Clinical utility of magnetic resonance thermal imaging (MRTI) for realtime guidance of deep hyperthermia. Proc SPIE Int Soc Opt Eng 2009;7181.
  • van Rhoon GC, Wust P. Introduction: Non-invasive thermometry for thermotherapy. Int J Hyperthermia 2005;21:489–95.
  • Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imaging 2008;27:376–90.
  • Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000;12:525–33.
  • Lüdemann L, Włodarczyk W, Nadobny J, Weihrauch M, Gellermann J, Wust P. Non-invasive magnetic resonance thermography during regional hyperthermia. Int J Hyperthermia 2010;26:273–82.
  • Kim Y. Advances in MR image-guided high-intensity focused ultrasound therapy. Int J Hyperthermia 2015;31:225–32.
  • Gellermann J, Faehling H, Mielec M, Cho CH, Budach V, Wust P. Image artifacts during MRT hybrid hyperthermia – causes and elimination. Int J Hyperthermia 2008;24:327–35.
  • Schmitt A, Mougenot C, Chopra R. Spatiotemporal filtering of MR-temperature artifacts arising from bowel motion during transurethral MR-HIFU. Med Phys 2014;41:113302.
  • Zachiu C, Denis de Senneville B, Moonen C, Ries M. A framework for the correction of slow physiological drifts during MR-guided HIFU therapies: Proof of concept. Med Phys 2015;42:4137–48.
  • Gellermann J, Weihrauch M, Cho CH, Włodarczyk W, Fähling H, Felix R, et al. Comparison of MR-thermography and planning calculations in phantoms. Med Phys 2006;33:3912–20.
  • Hofstetter LW, Yeo DTB, Dixon WT, Kempf JG, Davis CE, Foo TK. Fat-referenced MR thermometry in the breast and prostate using IDEAL. J Magn Reson Imaging 2012;36:722–32.
  • Kirchhoff G. Ueberdas Verhältniss zwischen dem Emissionsvermögen und dem Absorptionsvermögen der Körper für Wärme und Licht [On the relation between the radiating and absorbing powers of different bodies for light and heat]. Ann Phys Chem 1860;185:275–301.
  • Hand JW. Physical techniques for delivering microwave energy to tissues. Br J Cancer Suppl 1982;5:9–15.
  • Stauffer PR, Snow BW, Rodrigues DB, Salahi S, Oliveira TR, Reudink D, et al. Non-invasive measurement of brain temperature with microwave radiometry: Demonstration in a head phantom and clinical case. Neuroradiol J 2014;27:3–12.
  • Klemetsen O, Birkelund Y, Jacobsen SK, Maccarini PF, Stauffer PR. Design of medical radiometer front-end for improved performance. Prog Electromagn Res B 2011;27:289–306.
  • Stauffer PR, Rodriques DB, Salahi S, Topsakal E, Oliveira TR, Prakash A, et al. Stable microwave radiometry system for long term monitoring of deep tissue temperature. Proc SPIE Int Soc Opt Eng 2013;85840R.
  • Snow BW, Arunachalam K, De Luca V, Maccarini PF, Klemetsen O, Birkelund Y, et al. Non-invasive vesicoureteral reflux detection: Heating risk studies for a new device. J Pediatr Urol 2011;7:624–30.
  • Birkelund Y, Klemetsen O, Jacobsen SK, Arunachalam K, Maccarini PF, Stauffer PR. Vesicoureteral reflux in children: A phantom study of microwave heating and radiometric thermometry of pediatric bladder. IEEE Trans Biomed Eng 2011;58: 3269–78.
  • Arunachalam K, Maccarini PF, De Luca V, Bardati F, Snow BW, Stauffer PR. Modeling the detectability of vesicoureteral reflux using microwave radiometry. Phys Med Biol 2010;55:5417–35.
  • Jacobsen S, Stauffer PR. Can we settle with single-band radiometric temperature monitoring during hyperthermia treatment of chestwall recurrence of breast cancer using a dual-mode transceiving applicator? Phys Med Biol 2007;52:911–28.
  • Stauffer PR, Maccarini PF, Arunachalam K, De Luca V, Salahi S, Boico A, et al. Microwave radiometry for non-invasive detection of vesicoureteral reflux (VUR) following bladder warming. Proc SPIE Int Soc Opt Eng 2011;79010V
  • Hand JW, van Leeuwen GM, Mizushina S, van de Kamer JB, Maruyama K, Sugiura T, et al. Monitoring of deep brain temperature in infants using multi-frequency microwave radiometry and thermal modelling. Phys Med Biol 2001;46:1885–903.
  • Jacobsen S, Stauffer P. Non-invasive temperature profile estimation in a lossy medium based on multi-band radiometric signals sensed by a microwave dual-purpose body-contacting antenna. Int J Hyperthermia 2002;18:86–103.
  • Arunachalam K, Maccarini P, De Luca V, Tognolatti P, Bardati F, Snow B, et al. Detection of vesicoureteral reflux using microwave radiometry-system characterization with tissue phantoms. IEEE Trans Biomed Eng 2011;58:1629–36.
  • Rodrigues DB, Maccarini PF, Salahi S, Oliveira TR, Pereira PJS, Limao-Vieira P, et al. Design and optimization of an ultra wideband and compact microwave antenna for radiometric monitoring of brain temperature. IEEE Trans Biomed Eng 2014;61:2154–60.
  • Lewis MA, Staruch RM, Chopra R. Thermometry and ablation monitoring with ultrasound. Int J Hyperthermia 2015;31:163–81.
  • Lai C-Y, Kruse DE, Caskey CF, Stephens DN, Sutcliffe PL, Ferrara KW. Noninvasive thermometry assisted by a dual-function ultrasound transducer for mild hyperthermia. IEEE Trans Ultrason Ferroelectr Freq Control 2010;57:2671–84.
  • Foiret J, Ferrara KW. Spatial and temporal control of hyperthermia using real time ultrasonic thermal strain imaging with motion compensation, phantom study. PLoS One 2015;10:e0134938.
  • Bayat M, Ballard JR, Ebbini ES. In vivo ultrasound thermography in presence of temperature heterogeneity and natural motions. IEEE Trans Biomed Eng 2015;62:450–7.
  • Seip R, Ebbini ES. Noninvasive estimation of tissue temperature response to heating fields using diagnostic ultrasound. IEEE Trans Biomed Eng 1995;42:828–39.
  • Maass-Moreno R, Damianou CA. Noninvasive temperature estimation in tissue via ultrasound echo-shifts. Part I. Analytical model. J Acoust Soc Am 1996;100:2514–21.
  • Arnal B, Pernot M, Tanter M. Monitoring of thermal therapy based on shear modulus changes: I. shear wave thermometry. IEEE Trans Ultrason Ferroelectr Freq Control 2011;58:369–78.
  • Brosses ES, Pernot M, Tanter M. The link between tissue elasticity and thermal dose in vivo. Phys Med Biol 2011;56:7755–65.
  • Schooneveldt G, Kok HP, Balidemaj E, Geijsen ED, van Ommen F, Bakker A, et al. Thermal dosimetry for loco-regional radiofrequency hyperthermia treatment of the bladder: Accurate fluid modelling. 2016;[In preparation].
  • Gellermann J, Wust P, Stalling D, Seebass M, Nadobny J, Beck R, et al. Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. Int J Radiat Oncol Biol Phys 2000;47:1145–56.
  • Sreenivasa G, Gellermann J, Rau B, Nadobny J, Schlag P, Deuflhard P, et al. Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys 2003;55:407–19.
  • van Haaren PMA, Kok HP, van den Berg CAT, Vörde Sive Vörding PJ Zum, Oldenborg S, Stalpers LJA, et al. On verification of hyperthermia treatment planning for cervical carcinoma patients. Int J Hyperthermia 2007;23:303–14.
  • Franckena M, Canters R, Termorshuizen F, van der Zee J, van Rhoon G. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 2010;26:145–57.
  • Rijnen Z, Bakker JF, Canters RAM, Togni P, Verduijn GM, Levendag PC, et al. Clinical integration of software tool VEDO for adaptive and quantitative application of phased array hyperthermia in the head and neck. Int J Hyperthermia 2013;29:181–93.
  • Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948;1:93–122.
  • Turner PF. Regional hyperthermia with an annular phased array. IEEE Trans Biomed Eng 1984;31:106–14.
  • Wust P, Gellermann J, Beier J, Wegner S, Tilly W, Tröger J, et al. Evaluation of segmentation algorithms for generation of patient models in radiofrequency hyperthermia. Phys Med Biol 1998;43:3295–307.
  • Wust P, Seebass M, Nadobny J, Deuflhard P, Mönich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia 1996;12:477–94.
  • Kok HP, Van Haaren PMA, van de Kamer JB, Wiersma J, Van Dijk JDP, Crezee J. High-resolution temperature-based optimization for hyperthermia treatment planning. Phys Med Biol 2005;50:3127–41.
  • Wiersma J, van Maarseveen RAM, van Dijk JDP. A flexible optimization tool for hyperthermia treatments with RF phased array systems. Int J Hyperthermia 2002;18:73–85.
  • de Greef M, Kok HP, Correia D, Borsboom P-P, Bel A, Crezee J. Uncertainty in hyperthermia treatment planning: The need for robust system design. Phys Med Biol 2011;56:3233–50.
  • Kotte AN, van Leeuwen GM, Lagendijk JJ. Modelling the thermal impact of a discrete vessel tree. Phys Med Biol 1999;44:57–74.
  • Kok HP, van den Berg CAT, Bel A, Crezee J. Fast thermal simulations and temperature optimization for hyperthermia treatment planning, including realistic 3D vessel networks. Med Phys 2013;40:103303.
  • Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol 1996;41:2251–69.
  • Gabriel C, Gabriel S. Compilation of the dielectrical properties of body tissues at RF and microwave frequencies. Report no.: AL/OE-TR-1996-0037. Brooks Air Force Base Texas: Armstrong Laboratory, 1996.
  • Peyman A, Gabriel C. Dielectric properties of porcine glands, gonads and body fluids. Phys Med Biol 2012;57:N339–44.
  • Katscher U, Voigt T, Findeklee C, Vernickel P, Nehrke K, Dossel O. Determination of electric conductivity and local SAR via B1 mapping. IEEE Trans Med Imaging 2009;28:1365–74.
  • Liu J, Zhang X, Schmitter S, Van de Moortele P-F, He B. Gradient-based electrical properties tomography (gEPT): A robust method for mapping electrical properties of biological tissues in vivo using magnetic resonance imaging. Magn Reson Med 2015;74:634–46.
  • van Lier ALHMW, Raaijmakers A, Voigt T, Lagendijk JJW, Luijten PR, Katscher U, et al. Electrical properties tomography in the human brain at 1.5, 3, and 7T: A comparison study. Magn Reson Med 2014;71:354–63.
  • Balidemaj E, van Lier ALHMW, Crezee H, Nederveen AJ, Stalpers LJA, van den Berg CAT. Feasibility of electric property tomography of pelvic tumors at 3 T. Magn Reson Med 2015;73:1505–13.
  • Balidemaj E, de Boer P, van Lier ALHMW, Remis RF, Stalpers LJA, Westerveld GH, et al. In vivo electric conductivity of cervical cancer patients based on B1+ maps at 3 T MRI. Phys Med Biol 2016;61:1596–1607 accepted.
  • Balidemaj E, Kok HP, Schooneveldt G, van Lier ALHMW, Remis RF, Stalpers LJA, et al. Hyperthermia treatment planning for cervical cancer patients based on electric conductivity tissue properties acquired in vivo with EPT at 3 T MRI. Int J Hyperthermia 2016; accepted.
  • Fu F, Xin SX, Chen W. Temperature- and frequency-dependent dielectric properties of biological tissues within the temperature and frequency ranges typically used for magnetic resonance imaging-guided focused ultrasound surgery. Int J Hyperthermia 2014;30:56–65.
  • Walker DC, Smallwood RH, Keshtar A, Wilkinson BA, Hamdy FC, Lee JA. Modelling the electrical properties of bladder tissue – quantifying impedance changes due to inflammation and oedema. Physiol Meas 2005;26:251–68.
  • Lagendijk JJ, Hofman P, Schipper J. Perfusion analyses in advanced breast carcinoma during hyperthermia. Int J Hyperthermia 1988;4:479–95.
  • Inman BA, Etienne W, Rubin R, Owusu RA, Oliveira TR, Rodriques DB, et al. The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment. Int J Hyperthermia 2013;29:206–10.
  • Fatehi D, van der Zee J, Wielheesen DHM, van Wieringen WN, van Rhoon GC. Intra-luminal thermometry: Is tissue type assignment a necessity for thermal analysis? Int J Hyperthermia 2006;22:463–73.
  • Kiss B, Schneider S, Thalmann GN, Roth B. Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer? Thermochemotherapy for superficial BC. Int J Urol 2015;22:158–62.
  • Colombo R. Combined treatment with local thermo-chemotherapy for non muscle invasive bladder cancer. The present role in the light of acquired data and preliminary cumulative clinical experiences. Arch Ital Urol Androl 2008;80:149–56.
  • Dubois L, Sozanski J-P, Tessier V, Camart J-C, Fabre J-J, Pribetich J, et al. Temperature control and thermal dosimetry by microwave radiometry in hyperthermia. IEEE Trans Microw Theory Tech 1996;44:1755–61.
  • Numan WCM, Hofstetter LW, Kotek G, Bakker JF, Fiveland EW, Houston GC, et al. Exploration of MR-guided head and neck hyperthermia by phantom testing of a modified prototype applicator for use with proton resonance frequency shift thermometry. Int J Hyperthermia 2014;30:184–91.
  • Verhaart RF, Rijnen Z, Fortunati V, Verduijn GM, van Walsum T, Veenland JF, et al. Temperature simulations in hyperthermia treatment planning of the head and neck region: Rigorous optimization of tissue properties. Strahlenther Onkol 2014;190:1117–24.
  • Verhaart RF, Verduijn GM, Fortunati V, Rijnen Z, van Walsum T, Veenland JF, et al. Accurate 3D temperature dosimetry during hyperthermia therapy by combining invasive measurements and patient-specific simulations. Int J Hyperthermia 2015;31:686–92.
  • Tarasek MR, Pellicer R, Hofstetter LW, Numan WCM, Bakker JF, Kotek G, et al. Validation of MR thermometry: Method for temperature probe sensor registration accuracy in head and neck phantoms. Int J Hyperthermia 2014;30:142–9.